Vanguard Investments Australia’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.4M Buy
106,644
+839
+0.8% +$102K 0.03% 451
2026
Q1
$17.3M Buy
+105,805
New +$16.3M 0.05% 328

Other funds holding INSM

Vanguard Investments Australia's INSM Position: Q2 2026 in Review

Vanguard Investments Australia increased its Insmed (INSM) stake by 0.79% in Q2 2026, buying an estimated $102K and bringing the position to 106,644 shares worth $11.4M. The position accounts for 0.03% of the portfolio, ranked #451.

Vanguard Investments Australia first reported a position in INSM in Q1 2026 and has held it in 2 quarters since. The position peaked at $17.3M in Q1 2026. 609 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Vanguard Investments Australia held 106,644 shares of Insmed worth $11.4M as of Q2 2026.
  • Vanguard Investments Australia bought 839 Insmed shares in Q2 2026, an estimated $102K.
  • Insmed made up 0.03% of Vanguard Investments Australia's portfolio in Q2 2026, its #451 holding.
  • Vanguard Investments Australia first reported a position in Insmed in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Investments Australia's Insmed position peaked at $17.3M in Q1 2026.
  • 609 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Vanguard Investments Australia's 13F filing for Q2 2026, filed 13 Aug 2026.